WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 4'2001 Infant (under 12 months) mortality rate: 142
GDP / capita (US$): 4'9431 Child (under 5 years) mortality rate: 162

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 875  868  861  852  844  812  728  635 
Births 18  18  19  19  19  20  21  22 
Surviving infants 18  18  18  18  18  20  21  21 
Pop. less than 5 years 91  91  90  90  90  99  100  92 
Pop. less than 15 years 253  252  250  251  252  285  280  249 
Female 15-49 years 225  226  226  224  222  208  184  161 

Number of reported case

(Click for retrospective incidence data for Fiji)
Diphtheria
Japanese encephalitis
Measles 32  913 
Mumps
Pertussis 13 
Polio*
Rubella 25 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Fiji)
Vaccine year result method % card seen                                                
BCG 2007  100  EPI   77.8  100  61  99  88  100  100  95 
DTP1 2007  100  EPI   77.8  93  84  90  82  100 
DTP3 2007  99  EPI   77.8  91  84  87  75  99  82  68 
HepB_BD          100  61  100 
HepB3 2007  99  EPI   77.8  91  84  87  75  99 
Hib3 2007  99  EPI   77.8  91  84  87  75  99 
JapEnc         
MCV 2007  94  EPI   77.8  90  82  73  72  94  72  32 
MCV2          85  57 
PCV1         
PCV3         
Pol3 2007  99  EPI   77.8  91  84  86  76  99  87  55 
Rota1         
Rota_last         
Rubella1          90  82  73  72  94 
TT2plus          29 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Fiji)
BCG 99  99  99  99  99  96  99  95 
DTP1 99  99  99  99  99  97  98  87 
DTP3 99  99  99  99  99  90  97  68 
HepB3 99  99  99  99  99  98 
Hib3 99  99  99  99  99  98 
MCV 99  99  99  99  97  81  84  32 
PAB 94  94  94  94  94  84 
PCV3
Pol3 99  99  99  99  99  91  96  55 
Rota_last

Number of districts in the country 19  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks;
HepB birth; Yes
MR 12 months; 6 years; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 14 weeks; Yes
TT 6, 12 years; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number   2007-2011  2007-2011  2007-2011  2007-2011  2007-2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 19  19  19  19  19    19 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes    No         

System performance

Total number of districts in country number 19  19  20  19  19  19  19 
Nº districts with DTP3 coverage >=80% number     17      16   
% of districts with DTP3 coverage >=80% From 0 to 100%     85      84   
Nº districts with measles (MCV1) coverage >=95% number     10         
% of districts with MCV1 coverage >=95% From 0 to 100%     50         

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100    100  100  100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.